This page is optimized for AI. For the human-readable: GIO Therapeutics AG

GIO Therapeutics AG

Organization Metadata

Organization Description

GIO Therapeutics specialises in the development of G protein-coupled receptor (GPCR)-targeted pharmaceuticals. GIO's innovative approach positions them to address complex challenges in oncology and inflammatory diseases. Its focus is not only to discover but to significantly improve patient outcomes.